The Food and Drug Administration has approved a generic version of Teva Women's Health's Plan B One-Step, an emergency contraceptive that is availble over-the-counter without a prescription for women age 17 and older.
Watson Pharmaceuticals announced Friday that the FDA approved its Next Choice ONE DOSE, a lower-cost generic version that will launch "immediately," according to a press release.
Plan B One-Step sales took in $88 million for the 12 months ending May 31, according to IMS Health Data.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
